Lithium citrate for Canavan disease.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Pediatric Neurology

• Publication date

  2005-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.PEDIATRNEUROL.2005.04.015PMID 16194720
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain N-acetylaspartate as a molecular water pump and its role in the etiology of canavan disease

  2007cited by this paper
• Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease.

  2005cited by this paper
• Lithium-induced alterations in nucleoside triphosphate levels in human brain: a proton-decoupled 31P magnetic resonance spectroscopy study.

  2005cited by this paper
• Immunohistochemical localization of aspartoacylase in the rat central nervous system

  2004cited by this paper
• 1H MRS Study of Dorsolateral Prefrontal Cortex in Healthy Individuals before and after Lithium Administration

  2004cited by this paper
• Lithium selectively increases neuronal differentiation of hippocampal neural progenitor cells both in vitro and in vivo

  2004cited by this paper
• Chronic lithium decreases Nurr1 expression in the rat brain and impairs spatial discrimination.

  2004cited by this paper
• BDNF overexpression produces a long‐term increase in myelin formation in the peripheral nervous system

  2004cited by this paper
• N-Acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain.

  2004cited by this paper
• Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?

  2004cited by this paper
• NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes.

  2004cited by this paper
• Chronic lithium and sodium valproate both decrease the concentration of myoinositol and increase the concentration of inositol monophosphates in rat brain.

  2003cited by this paper
• Molecular targets of lithium action.

  2003cited by this paper
• Developmental increase of aspartoacylase in oligodendrocytes parallels CNS myelination.

  2003cited by this paper
• Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients

  2003cited by this paper
• Activation by N‐Acetyl‐l‐Aspartate of Acutely Dissociated Hippocampal Neurons in Rats via Metabotropic Glutamate Receptors

  2003cited by this paper
• Lithium stimulates progenitor proliferation in cultured brain neurons.

  2003cited by this paper
• Gene Therapy of Canavan Disease: AAV-2 Vector for Neurosurgical Delivery of Aspartoacylase Gene (ASPA) to the Human Brain

  2002influential reference
• Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease.

  2002cited by this paper
• The Effects of Lithium Chloride and Other Substances on Levels of Brain N-Acetyl-L-Aspartic Acid in Canavan Disease-Like Rats

  2002cited by this paper
• Intraneuronal N‐acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin‐associated aspartoacylase

  2001cited by this paper
• Developmental and regional distribution of aspartoacylase in rat brain tissue

  2001cited by this paper
• Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders

  2001cited by this paper
• Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.

  2000cited by this paper
• Effects of ethanol and of alcohol dehydrogenase inhibitors on the reduction of N-acetylaspartate levels of brain in mice in vivo: a search for substances that may have therapeutic value in the treatment of Canavan disease

  2000cited by this paper
• Epileptic seizures induced by N-acetyl-L-aspartate in rats: in vivo and in vitro studies.

  2000cited by this paper
• Carnitine: An osmolyte that plays a metabolic role

  2000cited by this paper
• Accumulation of N‐Acetyl‐L‐Aspartate in the Brain of the Tremor Rat, a Mutant Exhibiting Absence‐Like Seizure and Spongiform Degeneration in the Central Nervous System

  2000cited by this paper
• Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

  2000cited by this paper
• Neurotoxicity of NAAG in vivo is sensitive to NMDA antagonists and mGluR II ligands

  2000cited by this paper
• Lithium-induced increase in human brain grey matter.

  2000cited by this paper
• A method for fast multislice T1 measurement: Feasibility studies on phantoms, young children, and children with canavan's disease

  2000cited by this paper
• Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression

  1999cited by this paper
• Hypothesis: Molecular water pumps and the aetiology of Canavan disease: A case of the sorcerer's apprentice

  1999cited by this paper
• Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.

  1999influential reference
• Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons.

  1999influential reference
• Methods of measuring spin-lattice ( T 1 ) relaxation times: an annotated bibliography

  1999cited by this paper
• Astroglia Contain a Specific Transport Mechanism for N‐Acetyl‐l‐Aspartate

  1999cited by this paper
• Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes

  1999cited by this paper
• N-Acetyl Aspartate: A Marker for Neuronal Loss or Mitochondrial Dysfunction

  1998cited by this paper
• Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx.

  1998cited by this paper
• Age-related changes in the pediatric brain: quantitative MR evidence of maturational changes during adolescence.

  1997cited by this paper
• A molecular mechanism for the effect of lithium on development.

  1996cited by this paper
• Nerve Growth Factor and Neurotrophin-3 Differentially Regulate the Proliferation and Survival of Developing Rat Brain Oligodendrocytes

  1996cited by this paper
• Investigation into the Role of N‐Acetylaspartate in Cerebral Osmoregulation

  1995cited by this paper
• N-acetylaspartate as an acetyl source in the nervous system.

  1995cited by this paper
• The effect of N-acetylaspartate on the intracellular free calcium concentration in NTera2-neurons.

  1995cited by this paper
• Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy

  1993cited by this paper
• Estimation of metabolite concentrations from localized in vivo proton NMR spectra

  1993cited by this paper
• Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra.

  1993cited by this paper
• Specific Expression of N‐Acetylaspartate in Neurons, Oligodendrocyte‐Type‐2 Astrocyte Progenitors, and Immature Oligodendrocytes In Vitro

  1992cited by this paper
• Immunohistochemical localization of N-acetylaspartate in rat brain.

  1991cited by this paper
• N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.

  1989cited by this paper
• Normal maturation of the neonatal and infant brain: MR imaging at 1.5 T.

  1988cited by this paper
• Systemic lithium administration alters rat cerebral cortex phospholipids.

  1987cited by this paper
• Developmental features of the neonatal brain: MR imaging. Part II. Ventricular size and extracerebral space.

  1987cited by this paper
• Spatial Localization in NMR Spectroscopy in Vivo

  1987cited by this paper
• Developmental features of the neonatal brain: MR imaging. Part I. Gray-white matter differentiation and myelination.

  1987cited by this paper
• High concentrations of N-acetylaspartylglutamate (NAAG) selectively activate NMDA receptors on mouse spinal cord neurons in cell culture

  1986cited by this paper
• Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.

  1982cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper
• Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport.

  1979cited by this paper
• ACETATE METABOLISM IN THE NERVOUS SYSTEM. N‐ACETYL‐l‐ASPARTIC ACID AND THE BIOSYNTHESIS OF BRAIN LIPIDS *

  1966cited by this paper
• Studies on the distribution of N-acetyl-L-aspartic acid in brain.

  1957cited by this paper

• Substrate translocation and inhibition in human dicarboxylate transporter NaDC3

  2024cites this paper
• Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease

  2024cites this paper
• An unusual case of a toddler with Canavan disease with frequent intractable seizures: A case report and review of the literature

  2023cites this paper
• The pathogenesis of, and pharmacological treatment for, Canavan disease.

  2022cites this paper
• Development of bisubstrate analog inhibitors of aspartate N‐acetyltransferase, a critical brain enzyme

  2020cites this paper
• Canavan Disease: Clinical and Laboratory Profile from Southern Part of India

  2020cites this paper
• Canavan Disease (Aspartoacylase Deficiency): Report of the First Case in Basque Country and a Novel Mutation in Europe

  2019cites this paper
• Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases

  2019cites this paper
• Degenerative Disorders of the Newborn

  2018cites this paper
• Non-genetic therapeutic approaches to Canavan disease.

  2016influential citation
• Long-Term Follow-Up After Gene Therapy for

  2016cites this paper
• The state of treatment approach and diagnostics in Canavan disease with focus on the determination of N-acetylasparic acid

  2016cites this paper
• Canavan disease: an Arab scenario.

  2015cites this paper
• Astroglial Redistribution of Aquaporin 4 During Spongy Degeneration in a Canavan Disease Mouse Model

  2014cites this paper
• Evidence that lithium Inhibits Export of N-Acetyl-L-Aspartate from Neurons: A Retrospective Study of Canavan Disease and Bipolar Disorder Patients

  2014influential citation
• Canavan disease: Clinical features and recent advances in research

  2014cites this paper
• Clinical applications involving CNS gene transfer.

  2014cites this paper
• Wnt and lithium: a common destiny in the therapy of nervous system pathologies?

  2013cites this paper
• A thematic review of scientific and family interests in Canavan Disease: where are the developmentalists?

  2013cites this paper
• SLC13 family of Na⁺-coupled di- and tri-carboxylate/sulfate transporters.

  2013cites this paper
• Leukodystrophies with astrocytic dysfunction.

  2013cites this paper
• Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions.

  2013cites this paper
• Disorders & Genetic Reports

  2013cites this paper
• Long-Term Follow-Up After Gene Therapy for Canavan Disease

  2012cites this paper
• Lithium citrate as treatment of Canavan disease.

  2012cites this paper
• Lihium and the appLication of its compounds in different fieLds of medicine

  2012cites this paper
• Canavan Disease: A Neurometabolic Disease Caused By Aspartoacylase Deficiency

  2011cites this paper
• Canavan disease: a novel mutation.

  2011cites this paper
• Current opinion in pediatric metabolic disease

  2011cites this paper
• Journal of Pediatric Sciences

  2011cites this paper
• Neuro-Ophthalmologic Manifestations of Neurodegenerative Disease in Childhood

  2010cites this paper
• Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease.

  2010cites this paper
• The Genetics of Myelination in Metabolic Brain Disease: The Leukodystrophies

  2009cites this paper
• Pathogenesis of CNS involvement in disorders of amino and organic acid metabolism

  2008cites this paper
• Staying at the crossroads: assessment of the potential of serum lithium monitoring in predicting an ideal lithium dose.

  2008cites this paper
• Stable isotope dilution analysis of N-acetylaspartic acid in urine by liquid chromatography electrospray ionization tandem mass spectrometry.

  2007cites this paper
• Natural History of Canavan Disease Revealed by Proton Magnetic Resonance Spectroscopy (1H‐MRS) and Diffusion-weighted MRI

  2006cites this paper
• Mild‐onset presentation of Canavan's disease associated with novel G212A point mutation in aspartoacylase gene

  2006cites this paper
• Canavan disease: a white matter disorder.

  2006cites this paper